155 related articles for article (PubMed ID: 36098470)
1. A single-centre, open-label, single-arm, fixed-sequence pharmacokinetic study of SHR3680 on repaglinide and bupropion in prostate cancer patients.
Dai T; Xu Z; Huang L; Wang Y; Zeng G; Ye M; Liu K; Zeng F; Jiang S; Han W; Cao J
Br J Clin Pharmacol; 2023 Feb; 89(2):874-886. PubMed ID: 36098470
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers.
Zhang F; Li Y; Hu J; Zhong J; Li H
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):339-352. PubMed ID: 30520001
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Pharmacokinetic Interaction and Safety of Atogepant Co-Administered with Acetaminophen or Naproxen in Healthy Participants: A Randomized Trial.
Boinpally R; Spaventa J; Chen K; Butler M
Clin Drug Investig; 2021 Jun; 41(6):557-567. PubMed ID: 33948911
[TBL] [Abstract][Full Text] [Related]
4. Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender.
Stewart JJ; Berkel HJ; Parish RC; Simar MR; Syed A; Bocchini JA; Wilson JT; Manno JE
J Clin Pharmacol; 2001 Jul; 41(7):770-8. PubMed ID: 11452710
[TBL] [Abstract][Full Text] [Related]
5. Comparative Bioavailability and Tolerability of a Single 2-mg Dose of 2 Repaglinide Tablet Formulations in Fasting, Healthy Chinese Male Volunteers: An Open-Label, Randomized-Sequence, 2-Period Crossover Study.
Zhai XJ; Hu K; Chen F; Lu YN
Curr Ther Res Clin Exp; 2013 Dec; 75():48-52. PubMed ID: 24465043
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of repaglinide in healthy caucasian and Japanese subjects.
Thomsen MS; Chassard D; Evène E; Nielsen KK; Jørgensen M
J Clin Pharmacol; 2003 Jan; 43(1):23-8. PubMed ID: 12520624
[TBL] [Abstract][Full Text] [Related]
7. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide.
Hatorp V; Hansen KT; Thomsen MS
J Clin Pharmacol; 2003 Jun; 43(6):649-60. PubMed ID: 12817528
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity.
Loboz KK; Gross AS; Williams KM; Liauw WS; Day RO; Blievernicht JK; Zanger UM; McLachlan AJ
Clin Pharmacol Ther; 2006 Jul; 80(1):75-84. PubMed ID: 16815319
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties of lansoprazole (30-mg enteric-coated capsules) and its metabolites: A single-dose, open-label study in healthy Chinese male subjects.
Song M; Gao X; Hang TJ; Wen AD
Curr Ther Res Clin Exp; 2009 Jun; 70(3):228-39. PubMed ID: 24683233
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics and bioavailability of monomethyl fumarate following a single oral dose of Bafiertam® (monomethyl fumarate) versus Vumerity® (diroximel fumarate).
Rousseau FS; Wang L; Sprague TN; Lategan TW; Berkovich RR
Mult Scler Relat Disord; 2023 Feb; 70():104500. PubMed ID: 36645997
[TBL] [Abstract][Full Text] [Related]
11. Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine.
Choi JS; Choi I; Choi DH
Pharmacol Rep; 2013; 65(5):1422-30. PubMed ID: 24399740
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine markedly raises the plasma concentrations of repaglinide.
Kajosaari LI; Niemi M; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
Clin Pharmacol Ther; 2005 Oct; 78(4):388-99. PubMed ID: 16198658
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin.
Tjandrawinata RR; Setiawati E; Putri RS; Gunawan VA; Ong F; Susanto LW; Nofiarny D
Clin Pharmacol; 2015; 7():69-75. PubMed ID: 25945069
[TBL] [Abstract][Full Text] [Related]
15. Absorption, metabolism and excretion of a single oral dose of (14)C-repaglinide during repaglinide multiple dosing.
van Heiningen PN; Hatorp V; Kramer Nielsen K; Hansen KT; van Lier JJ; De Merbel NC; Oosterhuis B; Jonkman JH
Eur J Clin Pharmacol; 1999 Sep; 55(7):521-5. PubMed ID: 10501822
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.
Li X; Wang C; Li T; Liu Y; Liu S; Tao Y; Ma Y; Gao X; Cao Y
BMC Pharmacol Toxicol; 2020 Nov; 21(1):80. PubMed ID: 33213527
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
Choi Y; Han H; Shin D; Lim KS; Yu KS
Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: a randomized, open-label, single-dose, two-way crossover study in healthy human subjects.
Tippabhotla SK; Betha MR; Gadiko C; Battula R; Nakkawar M; Cheerla R; Khan SM; Yergude S; Thota S; Vobalaboina V
Drug Res (Stuttg); 2013 May; 63(5):250-7. PubMed ID: 23526241
[TBL] [Abstract][Full Text] [Related]
19. Comparative Safety, Bioavailability, and Pharmacokinetics of Oral Dexamethasone, 4-mg and 20-mg Tablets, in Healthy Volunteers Under Fasting and Fed Conditions: A Randomized Open-label, 3-way Crossover Study.
Bashir Q; Acosta M
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):768-773. PubMed ID: 32900662
[TBL] [Abstract][Full Text] [Related]
20. Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide.
Kajosaari LI; Niemi M; Backman JT; Neuvonen PJ
Clin Pharmacol Ther; 2006 Mar; 79(3):231-42. PubMed ID: 16513447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
